Nuvectis Pharma Inc

NVCTStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$21.12

Today

+0.2%

YTD

+181.1%

About

Nuvectis Pharma Inc is a clinical-stage biopharmaceutical company that focuses on the treatment of serious unmet medical needs in oncology. The company is committed to developing innovative and effective cancer therapies that can improve the lives of patients. Operating in the healthcare sector, Nuvectis’ lead product, NXP800, is a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers. It also has a pipeline of other promising oncology drug candidates in development. Keep up to date on the latest share price changes by adding NVCT stock to your eToro watchlist.

Price chart

Closing price history for NVCT (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-14.39

P/S (TTM)0.00

P/B (TTM)34.23

Market cap$578.49M

Cap tierSmall-cap

Industry avg P/E-43.36

Profitability

Gross marginUnknown

EBIT margin0.00%

Net marginUnknown

ROE-168.24%

ROA-106.54%

Earnings & Revenue

Revenue (TTM)$0.00

Revenue growth (1Y)Unknown

EPS (TTM)-$1.28

Free cash flow$-18.35M

Total debt$0.00

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.96

Employees13

Next earnings3 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.